Open AccessP1202 THE PHARMACOKINETICS (PK) AND SAFETY OF A SINGLE DOSE OF ADEFOVIR DIPIVOXIL (ADV) IN CHILDREN AND ADOLESCENTS (AGED 2–17) WITH CHRONIC HEPATITIS B
Author(s) -
Étienne Sokal,
DA Kelly,
S. Wirth,
J. Mizerski,
Bing Lu,
K. Kleber,
Jaynam Shah,
G. A. Currie,
Carol Brosgart
Publication year - 2004
Publication title -
journal of pediatric gastroenterology and nutrition
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.206
H-Index - 131
eISSN - 1536-4801
pISSN - 0277-2116
DOI - 10.1097/00005176-200408000-00040
Subject(s) - medicine , adefovir , cmax , dosing , pharmacokinetics , hbeag , adverse effect , chronic hepatitis , hepatitis b , gastroenterology , pharmacology , hepatitis b virus , lamivudine , immunology , hbsag , virus